Results 331 to 340 of about 4,376,164 (395)

Gastrointestinal contrast agents: A diamagnetic approach

Magnetic Resonance in Medicine, 1988
AbstractThe clay minerals kaolin and bentonite are demonstrated as gastrointestinal contrast agents for MRI. Weak field dependence of the relaxation efficiency assures effectiveness of these agents at all field strengths in clinical use. These agents eliminate signals from their immediate environment and are not toxic. © 1988 Academic Press, Inc.
J J, Listinsky, R G, Bryant
openaire   +2 more sources

Psychotropic agents in functional gastrointestinal disorders

Current Opinion in Pharmacology, 2008
Functional gastrointestinal disorders (FGIDs) are common conditions diagnosed by established symptom-based criteria. Dysregulation of the brain-gut axis is emerging as the primary pathophysiologic mechanism for FGIDs; this opens avenues for newer treatment modalities.
Madhusudan, Grover, Douglas A, Drossman
openaire   +2 more sources

Gastrointestinal Contrast Agents

JAMA, 1983
THE TWO major categories of contrast agents currently used to opacify the lumen of the gastrointestinal (GI) tract are barium sulfate suspensions and the iodinated water-soluble materials. Despite an extensive experience with these contrast media in the GI tract, confusion remains over their proper utilization.
openaire   +1 more source

Gastrointestinal Toxicity of Chemotherapeutic Agents

Seminars in Oncology, 2006
Chemotherapy-induced toxicities commonly occur in sites within the gastrointestinal (GI) tract and account for dose-limiting effects. These toxicities are major contributing factors to dose reduction, delays, and cessation of cancer treatment. Through intensive therapies including surgery, combination chemotherapy, hormonal therapy, and targeted ...
openaire   +3 more sources

Ginger (Zingiber officinale Rosc.) and its bioactive components are potential resources for health beneficial agents

Phytotherapy Research, 2020
Zingiber officinale Rosc. (Zingiberacae), commonly known as ginger, is a perennial and herbaceous plant with long cultivation history. Ginger rhizome is one of the most popular food spices with unique pungent flavor and is prescribed as a well‐known ...
Mengmeng Zhang, Rong Zhao, Dan Wang, Li Wang, Qing Zhang, Shujun Wei, Feng Lu, W. Peng, Chunjie Wu   +8 more
semanticscholar   +1 more source

Erythromycin as a gastrointestinal prokinetic agent

Intensive and Critical Care Nursing, 2001
Erythromycin is a potent stimulator of gastrointestinal (GI) motility and can be a useful agent to treat GI stasis in patients who are critically ill. However, it is not licensed for this indication and has serious drug interactions which may limit its utility.
openaire   +2 more sources

Prokinetic agents for lower gastrointestinal motility disorders

Diseases of the Colon & Rectum, 1993
Prokinetic agents are currently being investigated as potential therapies for motility disorders of the lower gastrointestinal tract. Cholinergic agonists such as bethanechol are known to improve postoperative ileus but are limited because of side effects. Dopamine antagonists such as domperidone appear to have maximal prokinetic effect in the proximal
W E, Longo, A M, Vernava
openaire   +2 more sources

Antiinflamatory Agents Less Dangerous for Gastrointestinal Tract

Current Pharmaceutical Design, 2001
NSAIDs represent one of the most commonly used therapeutic drug groups world wide. 1.5% of the world's population is estimated as taking NSAIDs. However, their use is not risk free and gastrointestinal (GI) lesions do appear, which is indeed the main reason for their toxicity. Frequently (50%) NSAID-induced GI lesions are asymptomatic, and perforations
M, Rodríguez-Téllez, F, Argüelles, J M, Herrerías, D, Ledro, J, Esteban, J M, Herrerías   +5 more
openaire   +2 more sources

New therapeutic agents in gastrointestinal stromal tumours

Current Opinion in Oncology, 2019
Purpose of review The aim of this study was to provide an update on the most recent developments regarding systemic treatments in the various molecular subtypes of gastrointestinal stromal tumour (GIST). Recent findings Several novel direct inhibitors of KIT and PDGFRA have entered ...
Falkenhorst, Johanna, Hamacher, Rainer, Bauer, Sebastian   +2 more
openaire   +3 more sources

NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs

Expert Review of Clinical Pharmacology, 2018
NSAIDs are widely used to treat pain and rheumatic conditions, but they induce adverse events in different body systems, although the major, most frequent events occur in the upper and lower gastrointestinal (GI) tracts.
G. García-Rayado, Mercedes Navarro, Á. Lanas   +2 more
semanticscholar   +1 more source